As pharmaceutical markets become increasingly dynamic, health systems may benefit from shifting toward unit-level economic frameworks that evaluate cost and margin performance.
News|Podcasts|November 3, 2023
Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates
On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars.
Advertisement
On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars. Interviews include: Chelsee Jensen, PharmD, BCPS a senior pharmacy specialist and pharmaceutical formulary manager at Mayo Clinic, Prerakkumar Parikh, PharmD, director of Specialty Clinical Solutions at Magellan Rx Management, and Kimberly Maxfield, PhD, from the FDA.
For more Nexus 2023 coverage, visit
Key Takeaways:
- Jensen discusses biosimilar approval updates, trends biosimilars, and what health care professionals can expect in the future.
- Parikh discusses the impact of interchangeable biosimilars, their cost-saving benefits, and the influx of biosimilars into pharmacy.
- Maxfield discusses the role pharmacists can take to reassure patients when switching to a biosimilar and the future of biosimilar development.
Advertisement
Related to this article
The randomized ALLIANCE A051701 trial closed early when treatment-related toxicity and mortality were increased without improving PFS in patients with newly diagnosed double-hit lymphoma.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Robin Tumlinson, PharmD, BCOP, discusses how rapidly expanding bladder cancer options are creating new questions around treatment sequencing, toxicity management, biomarker testing, and multidisciplinary care.
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
A prospective observational study found microplastics more frequently and at higher levels in lung samples from patients with lung malignancies, although the findings do not establish that the particles cause cancer.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
2
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
3
Pharmacists' Role as Ketone Monitoring Reaches Clinics
4
From Reactive to Proactive: AI's Role in Modern Pharmacy Safety
5